Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbhfiledCriticalBoehringer Ingelheim International Gmbh
Publication of ECSP044966ApublicationCriticalpatent/ECSP044966A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Esta invención se relaciona con el polimorfo A de flibanserina (1), para un proceso técnico para la preparación del mismo, así como también para el uso del mismo para la preparación de medicamentos.This invention relates to flibanserin polymorph A (1), for a technical process for the preparation thereof, as well as for the use thereof for the preparation of medicaments.
ECSP0449662001-08-022004-01-30
FLIBANSERINE STABLE POLYMORPH COMPOSITE, INDUSTRIAL PROCEDURE FOR PREPARATION, AND USE OF IT TO PREPARE MEDICINES
ECSP044966A
(en)
COMPOUNDS DERIVED FROM PYRIMIDINS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF PSORIASIS, DIABETES, REUMATOID ARTHRITIS, AMONG OTHER DISEASES (DIVISIONAL APPLICATION 1147-02).
Aryl-isoxasol-imidazole derived compounds; preparation procedure; pharmaceutical composition containing them; and use in the preparation of useful drugs in the treatment of cognitive disorders and Alzheimer's-related diseases.
PIRAZOLO (4,3-E) NOVEL SUBSTITUTED DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THEIR USE AS MEDICINAL PRODUCTS AND PROCESSES TO PREPARE THEM